Search Results

Voglivib 0.2 - Voglibose 0.2 mg

VOGLIVIB 0.2 VOGLIBOSE 0.2mg. IP

Send Enquiry

CURE

Tablets

Packaging and packing Type

Alu Alu | 10x10

MRP :

₹106

PTR :

₹80.76

PTS :

₹72.69

Prescription medicineVoglivib 0.2 tablets contain voglibose 0.2 mg and are used to control blood sugar in type 2 diabetes. Read More

Composition

VOGLIBOSE 0.2mg. IP

Send Enquiry

Available on PCD franchise with monopoly rights: Cardiac and diabetic PCD franchise

India’s Trusted Pharma Brand

100%

Genuine Products

Secure

Payments

24 x 7

Customer Support

About the product

By Vibcare Pharma · Updated 9 October 2026 · Based on product labels and standard drug references

Description

Voglivib 0.2 is a tablet for oral use. Each tablet contains Voglibose 0.2 mg, and it belongs to the alpha-glucosidase inhibitor class of anti-diabetic medicines. It is packed as 10x10 (Alu Alu) and is available from Vibcare Pharma.

How it works

The active ingredient Voglibose acts in the small intestine. It slows down the enzymes that break down carbohydrates from food into sugar, so the sugar from a meal is absorbed at a slower and more even rate. This helps to soften the rise in blood sugar that normally happens after eating.

Used for

These tablets are meant for use in adults with type 2 diabetes mellitus, as an add-on to diet and exercise. Use only on a doctor's prescription.

Use only on a doctor's prescription, at the dose and for the duration advised.

Side Effects

Common

  • Flatulence (gas)
  • Abdominal distension or bloating
  • Loose motions (diarrhoea)
  • Stomach pain or discomfort
  • Nausea
  • Constipation
  • Rumbling sounds in the stomach

Get medical help at once if you notice

  • Severe stomach pain with vomiting (possible ileus or bowel obstruction)
  • Yellowing of eyes or skin, or liver-related symptoms
  • Severe allergic reaction with swelling or difficulty breathing

Uses

  • Used along with diet and exercise in type 2 diabetes mellitus
  • Helps control blood sugar levels after meals
  • Reduces post-meal rise in blood glucose
  • Used as an add-on when diet and exercise alone do not give enough control

Precautions

Do not use

  • Must not be used by patients allergic to voglibose
  • Must not be used in severe infection, diabetic ketoacidosis or diabetic precoma
  • Must not be used in type 1 diabetes
  • Must not be used before or after surgery, or after serious trauma

Ask a doctor first

  • Check with a doctor first if you have liver or kidney problems, bowel disease, a history of abdominal surgery, or are pregnant or breastfeeding, and if you also take insulin or a sulfonylurea, as low blood sugar may occur

For distributors and medical representatives

Voglivib 0.2 Tablet on PCD franchise

Voglivib 0.2 Tablet is part of Vibcare Pharma's cardiac and diabetic range. Take the range to your area as a PCD franchise partner, with monopoly rights in your district.

  • 1,500+products
  • Monopolyin your district
  • ₹20,000first order
  • Same-daydispatch

Cardiac and diabetic PCD franchisePCD pharma franchise with Vibcare

Voglivib 0.2 Tablet: frequently asked questions

What is Voglivib 0.2 Tablet used for?

Voglivib 0.2 tablets contain voglibose 0.2 mg and are used to control blood sugar in type 2 diabetes. Main uses: used along with diet and exercise in type 2 diabetes mellitus; helps control blood sugar levels after meals; reduces post-meal rise in blood glucose; used as an add-on when diet and exercise alone do not give enough control.

What are the side effects of Voglivib 0.2 Tablet?

Common side effects of Voglivib 0.2 Tablet include flatulence (gas); abdominal distension or bloating; loose motions (diarrhoea); stomach pain or discomfort; nausea; constipation. Get medical help at once if you notice severe stomach pain with vomiting (possible ileus or bowel obstruction); yellowing of eyes or skin, or liver-related symptoms; severe allergic reaction with swelling or difficulty breathing.

What is the dose of Voglivib 0.2 Tablet?

Each Voglivib 0.2 tablet contains Voglibose 0.2 mg. The right dose and how long to take it depend on the condition, age and other medicines, so use Voglivib 0.2 Tablet only as your doctor advises.

What is the price of Voglivib 0.2 Tablet?

The MRP of Voglivib 0.2 Tablet is ₹106 for a pack of 10x10 (Alu Alu). For chemists and distributors, the PTR is ₹80.76 and the PTS is ₹72.69.

What is the composition of Voglivib 0.2 Tablet?

Each Voglivib 0.2 tablet contains Voglibose 0.2 mg. It comes in a pack of 10x10 (Alu Alu).

How does Voglivib 0.2 Tablet work?

The active ingredient Voglibose acts in the small intestine. It slows down the enzymes that break down carbohydrates from food into sugar, so the sugar from a meal is absorbed at a slower and more even rate. This helps to soften the rise in blood sugar that normally happens after eating.

Who should not use Voglivib 0.2 Tablet?

Must not be used by patients allergic to voglibose. Must not be used in severe infection, diabetic ketoacidosis or diabetic precoma. Must not be used in type 1 diabetes. Must not be used before or after surgery, or after serious trauma. Check with a doctor first if you have liver or kidney problems, bowel disease, a history of abdominal surgery, or are pregnant or breastfeeding, and if you also take insulin or a sulfonylurea, as low blood sugar may occur.

Who markets Voglivib 0.2 Tablet, and is it available for PCD franchise?

Voglivib 0.2 Tablet is a brand of Vibcare Pharma, sold through its Cure division. It is available for PCD pharma franchise and distribution in India; use the Send Enquiry or WhatsApp button on this page to ask about availability and terms.

Looking into the future of healthcare

Contact

Plot No 4, HSIIDC IT PARK, Sector 22,Panchkula, Haryana, India 134109

Phone: 9888988858

Business Hours

Mon-Sat: 9AM to 6PM

Business Enquiry

Request a callback to get more information about becoming a Partner

    Send Enquiry

    Request a callback to get more information about becoming a PCD Franchise Owner

    Please enable JavaScript in your browser to complete this form.
    Do you have a Drug License?